Enhancement of leishmanicidal activity of human macrophages against Leishmania major and Leishmania donovani infection using recombinant human granulocyte macrophage colony stimulating factor.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Zentralblatt fur Bakteriologie : international journal of medical microbiology

• Publication date

  1996-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0934-8840(96)80027-2PMID 8946701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage Activation and Inactivation in Protozoal Infections

  1993cited by this paper
• Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages

  1993cited by this paper
• Hemopoietic growth factors and mononuclear phagocytes

  1993cited by this paper
• Haemopoietic growth factors I

  1992cited by this paper
• Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity.

  1992cited by this paper
• Interleukin-3 induces antimicrobial activity against Leishmania amazonensis and Trypanosoma cruzi and tumoricidal activity in human peripheral blood-derived macrophages

  1992cited by this paper
• Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections.

  1991cited by this paper
• Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration

  1991cited by this paper
• Recombinant Granulocyte–Macrophage Colony‐Stimulating Factor Activates Human Macrophages to Inhibit Growth or Kill Mycobacterium avium Complex

  1990cited by this paper
• Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness.

  1990cited by this paper
• Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.

  1990cited by this paper
• Granulocyte-macrophage colony stimulating factor induces both HLA-DR expression and cytokine production by human monocytes.

  1990cited by this paper
• Granulocyte/macrophage colony stimulating factor. A potent activation signal for mature macrophages and monocytes.

  1989cited by this paper
• Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor show common biological effects and binding characteristics on human monocytes.

  1989cited by this paper
• Granulocyte-macrophage colony-stimulating factor

  1989cited by this paper
• Physiology of granulocyte and macrophage colony-stimulating factors in host defense.

  1989cited by this paper
• Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.

  1989cited by this paper
• Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism.

  1988cited by this paper
• Haemopoietic growth factors

  1988cited by this paper
• Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.

  1988cited by this paper
• Diminished activity of protein kinase C in tetanus toxin-treated macrophages and in the spinal cord of mice manifesting generalized tetanus intoxication.

  1988cited by this paper
• Application of recombinant granulocyte‐macrophage colony‐stimulating factor has a detrimental effect in experimental murine leishmaniasis

  1988cited by this paper
• Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self.

  1988cited by this paper
• Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages

  1987cited by this paper
• Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma

  1987cited by this paper
• Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages.

  1987cited by this paper
• Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures.

  1987cited by this paper
• Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.

  1986cited by this paper
• A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.

  1986cited by this paper
• Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.

  1986cited by this paper
• Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.

  1986cited by this paper
• Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

  1986cited by this paper
• Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.

  1985cited by this paper
• Clinical manifestations, diagnosis and treatment of leishmaniasis.

  1985cited by this paper
• Potent activation of mouse macrophages by recombinant interferon-gamma.

  1984cited by this paper
• Activation of macrophages to kill rickettsiae and Leishmania: dissociation of intracellular microbicidal activities and extracellular destruction of neoplastic and helminth targets.

  1984cited by this paper
• Selective primary health care: strategies for control of disease in the developing world. XIV. Leishmaniasis.

  1984cited by this paper
• Intracellular destruction of Leishmania donovani and Leishmania tropica amastigotes by activated macrophages: dissociation of these microbicidal effector activities in vitro.

  1984cited by this paper
• Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

  1983cited by this paper
• Gaps in Therapy for Infectious Diseases: Conference Summary

  1982cited by this paper
• Clonal analysis of progenitor cell commitment to granulocyte or macrophage production

  1982cited by this paper
• Leishmanicidal mechanisms of human polymorphonuclear phagocytes.

  1981cited by this paper
• Fourth annual report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.

  1980cited by this paper
• Multiplication of Leishmania in human macrophages in vitro

  1979cited by this paper
• Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice

  1977cited by this paper
• Isolation of mononuclear cells and granulocytes from human blood.

  1968cited by this paper
• UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) STRATEGIC REVIEW OF TRAPS AND TARGETS FOR TSETSE AND AFRICAN TRYPANOSOMIASIS CONTROL

  year unknowncited by this paper

• A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil

  2020cites this paper
• Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis

  2020cites this paper
• Novel insights into leishmania biology : the role of parasite and host-derived small non-coding RNAs

  2015cites this paper
• The Immunopathology of Rheumatoid Arthritis and Leishmania donovani Infection in Sudan

  2013cites this paper
• Advances in leishmaniasis immunopathogenesis.

  2011cites this paper
• ADVANCES IN LEISHMANIASIS IMMUNOPATHOGENESIS

  2011cites this paper
• Interventions for American cutaneous and mucocutaneous leishmaniasis.

  2009cites this paper
• Circulating Immune Complexes (IC) and IC-Induced Levels of GM-CSF Are Increased in Sudanese Patients with Acute Visceral Leishmania donovani Infection Undergoing Sodium Stibogluconate Treatment: Implications for Disease Pathogenesis1

  2007cites this paper
• Implications for Disease Pathogenesis Sodium Stibogluconate Treatment : Infection Undergoing Leishmania donovani in Sudanese Patients with Acute Visceral IncreasedIC-Induced Levels of GM-CSF Are Circulating Immune Complexes ( IC ) and ElGhazali and

  2007cites this paper
• Immunopathology of Leishmaniasis: An Update

  2007cites this paper
• Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials.

  2005cites this paper
• Liposomal amphotericin B and rHuGM-CSF for treatment of visceral leishmaniasis in AIDS.

  2004cites this paper
• Recombinant Leishmania major Secreting Biologically Active Granulocyte-Macrophage Colony-Stimulating Factor Survives Poorly in Macrophages In Vitro and Delays Disease Development in Mice

  2003cites this paper
• Cyclosporin A-mediated killing of Leishmania major by macrophages is independent of reactive nitrogen and endogenous TNF-α and is not inhibited by IL-10 and 13

  2003cites this paper
• OXIDATIVE STRESS OF LIVER IN HAMSTERS INFECTED WITH LEISHMANIA (L.) CHAGASI

  2000cites this paper
• COMMENTARY Leishmania species: models of intracellular parasitism

  1999cites this paper
• Leishmania species: models of intracellular parasitism.

  1999cites this paper
• CONCISE COMMUNICATIONS Randomized, Double-Blind Study of Stibogluconate Plus Human Granulocyte Macrophage Colony-Stimulating Factor versus Stibogluconate Alone in the Treatment of Cutaneous Leishmaniasis

  1999cites this paper
• Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis.

  1999cites this paper
• EVASION OF MACROPHAGE MICROBICIDAL ACTIVITY AND TRANSFORMATION INTO AMASTIGOTES

  1999cites this paper
• List of papers

  1995cites this paper